Is Treatment for Early Alzheimer's Already Available?

Contributed by: Dennis Fortier, President, Medical Care Corporation
________________________________________________

A new study suggests that Memantine, a drug currently approved for treatment of the late stages of Alzheimer's disease, might also be effective in early stages.

In animal based experiments, rats were taught to find their way through a water maze and then given agents to induce brain inflammation. Consistent with theories suggesting that inflammation impairs cognitive function, the rats essentially "forgot" how to navigate the maze. However, once given Memantine, the rats' performance normalized and they were once again able to complete the maze.

Obviously, this is early-stage work but the hypothesis has theoretical validity and the earliest empirical data are encouraging.

A better understanding and more awareness of Alzheimer's related issues can impact personal health decisions and generate significant impact across a population of aging individuals. Please use the share button below to spread this educational message as widely as possible.